Speaker Profile

M.B.A., CEO and Co-Founder, Ariel Precision Medicine

Biography
Ms. Gibson is CEO and Co-Founder of Ariel Precision Medicine, an innovative precision medicine company, transforming genetic and clinical data into new insights for the diagnosis and therapeutic development for complex chronic conditions. She led the development, validation and commercial launch of Advance®, Ariel's AI fueled platform, which has supported the identification of new therapeutic targets for complex pancreatic diseases. She served as Chief Commercial Officer of Ariel Precision Medicine until 2016, bringing over 15 years of experience in healthcare, Biotech and Pharma from previous roles at Purdue, Shionogi Pharmaceuticals and Gene Wiz Inc. Early on in her career, she worked with the Center for Emergency Medicine, Gastroenterology research at University of Pittsburgh and research with the Cancer Institute. Ms. Gibson earned an Executive MBA from Liberty University and a Bachelor of Science in Emergency Medicine from the University of Pittsburgh and a Certification in Disruptive Strategy from Harvard Business School.


×

Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by MAR. 28TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts


Contact Us:

Fields marked with an * are required 

Discount also depends on group size. The bigger group – the bigger discount.

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required